Cargando…

Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas.

p27kip1 is a cyclin-dependent kinase inhibitor that regulates progression from G1 into S phase. Aberrations in cell cycle control are often observed in tumors and might even be necessary in tumor development. Recent reports showed that low p27kip1 expression is associated with poor prognosis in seve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Y. H., Park, C. K.
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Academy of Medical Sciences 2000
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054650/ https://www.ncbi.nlm.nih.gov/pubmed/10983687

Ejemplares similares

PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27(Kip1)
por: Pérez-Luna, Maria, et al.
Publicado: (2012)

E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27(KIP1)
por: St. Croix, Brad, et al.
Publicado: (1998)

Cyclin-Dependent Kinase Inhibitor P27(Kip1) Is Required for Mouse Mammary Gland Morphogenesis and Function
por: Muraoka, Rebecca S., et al.
Publicado: (2001)

Accelerated turnover of taste bud cells in mice deficient for the cyclin-dependent kinase inhibitor p27(Kip1)
por: Harrison, Theresa A, et al.
Publicado: (2011)

Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy
por: Ullah, Zakir, et al.
Publicado: (2009)

Expression of cyclin dependent kinase inhibitor p21WAF1 alone and in combination with p27KIP1 shows prognostic value in gastric carcinoma.
por: Jang, S. J., et al.
Publicado: (1998)

Editor's Note on ‘PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27(Kip1)’
Publicado: (2023)

Cyclin-Dependent Kinase Inhibitor p27(Kip1) Controls Growth and Cell Cycle Progression in Human Uterine Leiomyoma
por: Ramachandran, Sabarish, et al.
Publicado: (2008)

Cux1 regulation of the cyclin kinase inhibitor p27(kip1) in polycystic kidney disease is attenuated by HDAC inhibitors
por: Livingston, Safia, et al.
Publicado: (2019)

FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27(Kip1) in acute myeloid leukemia
por: Peschel, Ines, et al.
Publicado: (2017)

Regulation of expression by promoters versus internal ribosome entry site in the 5′-untranslated sequence of the human cyclin-dependent kinase inhibitor p27(kip1)
por: Liu, Zhaoqian, et al.
Publicado: (2005)

Immunohistochemical Expression of p27(Kip1), p57(Kip2), Cyclin D1, Nestin, and Ki-67 in Ependymoma
por: Iqneibi, Shahad, et al.
Publicado: (2022)

Phosphorylation of p27(Kip1) at Thr187 by Cyclin-dependent Kinase 5 Modulates Neural Stem Cell Differentiation
por: Zheng, Ya-Li, et al.
Publicado: (2010)

Genetic association between the cyclin-dependent kinase inhibitor gene p27/Kip1 polymorphism (rs34330) and cancer susceptibility: a meta-analysis
por: Cheng, Xiao-Ke, et al.
Publicado: (2017)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Two maize Kip-related proteins differentially interact with, inhibit and are phosphorylated by cyclin D–cyclin-dependent kinase complexes
por: Godínez-Palma, Silvia K., et al.
Publicado: (2017)

p27(Kip1) and Ser10-phosphorylated p27(Kip1) in breast cancer: clinical significance and expression
por: Song, Wei, et al.
Publicado: (2015)

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer
por: Chiarle, Roberto, et al.
Publicado: (2001)

Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells
por: Komata, T, et al.
Publicado: (2003)

The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer
por: Coley, H M, et al.
Publicado: (2012)

Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer
por: Kamai, T, et al.
Publicado: (2001)

Prognostic Implications of Cyclin B1, p34cdc2, p27(Kip1) and p53 Expression in Gastric Cancer
por: Kim, Dong-Hoon
Publicado: (2007)

Cardiac differentiation in Xenopus requires the cyclin-dependent kinase inhibitor, p27Xic1
por: Movassagh, Mehregan, et al.
Publicado: (2008)

Increased Expression of Cyclin D1, Cyclin E and p21(Cip1) Associated with Decreased Expression of p27(Kip1) in Chemically Induced Rat Mammary Carcinogenesis
por: Jang, Tae Jung, et al.
Publicado: (2000)

p27(Kip1) regulates alpha-synuclein expression
por: Gallastegui, Edurne, et al.
Publicado: (2018)

Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
por: Hur, Saem, et al.
Publicado: (2020)

Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation
por: Salamina, Marco, et al.
Publicado: (2021)

Regulation of p27(Kip1) and p57(Kip2) Functions by Natural Polyphenols
por: Russo, Gian Luigi, et al.
Publicado: (2020)

Effect of Xpcl1 Activation and p27(Kip1) Loss on Gene Expression in Murine Lymphoma
por: Kuppers, Daniel A., et al.
Publicado: (2011)

Lack of Sik1 in Mouse Embryonic Stem Cells Impairs Cardiomyogenesis by Down-Regulating the Cyclin-Dependent Kinase Inhibitor p57(kip2)
por: Romito, Antonio, et al.
Publicado: (2010)

Reduced Expression of Cyclin–dependent Kinase Inhibitor p27(Kipl) Is Associated with Advanced Stage and Invasiveness of Gastric Carcinomas
por: Yasui, Wataru, et al.
Publicado: (1997)

PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27(Kip1)
por: Nicholas, Courtney, et al.
Publicado: (2013)

Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1
por: Liu, Shuang, et al.
Publicado: (2012)

The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse
por: Bayrak, Aykut, et al.
Publicado: (2003)

Expression of Cyclin‐dependent Kinase Inhibitor p27/Kipl and AP‐1 Coactivator p38/Jabl Correlates with Differentiation of Embryonal Rhabdomyosarcoma
por: Tsuchida, Rika, et al.
Publicado: (2002)

Upregulation of p27 cyclin-dependent kinase inhibitor and a C-terminus truncated form of p27 contributes to G1 phase arrest
por: Satoh, Takayuki, et al.
Publicado: (2016)

p27(KIP1) is abnormally expressed in Diffuse Large B-Cell Lymphomas and is associated with an adverse clinical outcome
por: Sáez, Al, et al.
Publicado: (1999)

Protein Expression of Cell Cycle Regulator, p27(Kip1), Correlates with Histopathological Grade of Non‐Hodgkin's Lymphoma
por: Kudoh, Shiori, et al.
Publicado: (1999)

p27(Kip1) and p21(Cip1) collaborate in the regulation of transcription by recruiting cyclin–Cdk complexes on the promoters of target genes
por: Orlando, Serena, et al.
Publicado: (2015)

Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27
por: Wang, Huimin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_veitrdtn3sslboekisads6k7gh